Article

CIGB-300 Synthetic Peptide, an Antagonist of CK2 Kinase Activity, as a Treatment for Covid-19. A Computational Biology Approach

2021-08-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Similarities in the hijacking mechanisms used by SARS-CoV-2 and several type of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for the treatment of cancer. A recent study in cells infected with SARS-CoV-2 virus found a significant CK2 kinase activity, and the use of a CK2 inhibitor showed antiviral re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ea4750a5-2d75-5fad-b019-94baceb97657
DOI: 10.21203/rs.3.rs-795492/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CIGB-300 Synthetic Peptide, an Antagonist of CK2 Kinase Activity, as a Treatment for Covid-19. A Computational Biology ApproachDOI 10.21203/rs.3.rs-795492/v1Read

CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approachSemantic proximity Read

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read

Protein kinase CK2: a potential therapeutic target for diverse human diseases.Semantic proximity Read

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVIDSemantic proximity Read

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Semantic proximity Read

Polypharmacology is an enduring and nearly universal property of kinase inhibitorsSemantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read